SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-14-000870
Filing Date
2014-03-07
Accepted
2014-03-07 12:47:32
Documents
8
Period of Report
2014-03-07

Document Format Files

Seq Description Document Type Size
1 6-K zk1414559.htm 6-K 23305
2 EXHIBIT 1.1 exhibit_1-1.htm EX-1.1 280656
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 11039
4 EXHIBIT 5.2 exhibit_5-2.htm EX-5.2 17218
5 EXHIBIT 99.1 exhibit_99-1.htm EX-99.1 17204
6 logo.jpg GRAPHIC 6765
7 mor.jpg GRAPHIC 4093
8 arnon.jpg GRAPHIC 8095
  Complete submission text file 0001178913-14-000870.txt   376973
Mailing Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450
Business Address P.O. BOX 45158 19 HARTUM STREET JERUSALEM L3 91450 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-35223 | Film No.: 14676159
SIC: 2834 Pharmaceutical Preparations